Help | RSS Feed



Kalytera Therapeutics, Inc. (TSXV:KLY.V) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Kalytera Therapeutics, Inc. (TSXV:KLY.V) seasonal charts above shows that a Buy Date of December 27 and a Sell Date of March 31 has resulted in a geometric average return of 23.56% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 123.56% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Kalytera Therapeutics Inc develops cannabinoid (CBD) therapeutics for a range of unmet medical needs. CBD is a compound that shows activity against various pharmacological targets. The company develops CBD formulations and prodrugs to target specific disease sites within the body. Its programs include Bone Fracture Healing Program, Osteogenesis Imperfecta Program, Osteoporosis Program, and Osteoporosis in Prader-Willi syndrome.

To download KLY.V seasonal chart data, please log in or Subscribe.

 

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore